Lindbrook Capital’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-282
| Closed | -$1.7K | – | 2827 |
|
|
2024
Q2 | $1.7K | Hold |
282
| – | – | ﹤0.01% | 2393 |
|
|
2024
Q1 | $3.14K | Hold |
282
| – | – | ﹤0.01% | 2084 |
|
|
2023
Q4 | $4.2K | Buy |
+282
| New | +$4.2K | ﹤0.01% | 1979 |
|
|
2023
Q1 | – | Sell |
-215
| Closed | -$2.42K | – | 2776 |
|
|
2022
Q4 | $2.42K | Hold |
215
| – | – | ﹤0.01% | 2160 |
|
|
2022
Q3 | $2K | Hold |
215
| – | – | ﹤0.01% | 1976 |
|
|
2022
Q2 | $2K | Buy |
215
+81
| +60% | +$753 | ﹤0.01% | 1900 |
|
|
2022
Q1 | $2K | Buy |
+134
| New | +$2K | ﹤0.01% | 1930 |
|
|
2021
Q4 | – | Sell |
-400
| Closed | -$30K | – | 2063 |
|
|
2021
Q3 | $30K | Sell |
400
-800
| -67% | -$60K | 0.01% | 595 |
|
|
2021
Q2 | $66K | Buy |
+1,200
| New | +$66K | 0.01% | 387 |
|
|
2021
Q1 | – | Sell |
-700
| Closed | -$60K | – | 1862 |
|
|
2020
Q4 | $60K | Buy |
700
+550
| +367% | +$47.1K | 0.01% | 349 |
|
|
2020
Q3 | $6K | Buy |
+150
| New | +$6K | ﹤0.01% | 1000 |
|